FN1 and breast carcinoma: Zhu et al.65 have demonstrated MLN4924 impeded the transwell cell migration and invasion assay in line with decreased epithelial‐to‐mesenchymal transition (EMT) markers such as fibronectin and N‐cadherin in breast cancer cell line MDA‐MB‐231.